Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Congrats on putting yourself together and going for it, no matter what!
It’s good that you did it, and I believe in you. I only ask the original comment author not to dismiss the ways others are dealing with the problem. If novel research can help it, it’s good!
obligatory consult your medical specialist and don’t consume random drugs without prescription, this will end badly